NOD-like receptor protein 3 (NLRP3) inflammasome activation occurs in NAFLD, and blocking its activity improves the pathology and fibrosis in MCD-fed mice [137,138,139]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.